Monoclonal antibodies in the treatment of myelogenous leukemias.
Scheinberg
D A
DA
Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015703:Antigens, CD / Q000276:immunology; D015214:Antigens, Differentiation, Myelomonocytic / Q000276:immunology; D006801:Humans; D007951:Leukemia, Myeloid / Q000628:therapy*; D016256:Lewis X Antigen; D018950:Lipopolysaccharide Receptors; D051379:Mice; D016499:Radioimmunotherapy; D063268:Sialic Acid Binding Ig-like Lectin 3
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; C571163:CD33 protein, human; C571165:Cd33 protein, mouse; D016256:Lewis X Antigen; D018950:Lipopolysaccharide Receptors; D063268:Sialic Acid Binding Ig-like Lectin 3